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Objectives This study sought to determine whether mortality complicating ST-segment elevation myocardial infarction
(STEMI) was impacted by the design of transport systems.
Background It is recommended that regions develop systems to facilitate rapid transfer of STEMI patients to centers
equipped to perform primary percutaneous coronary intervention (PCI), yet the impact on mortality from the de-
sign of such systems remains unknown.
Methods Within the framework of a citywide system where all STEMI patients are referred for primary PCI, we compared
patients referred directly from the field to a PCI center to patients transported beforehand from the field to a
non–PCI-capable hospital. The primary outcome was all-cause mortality at 180 days.
Results A total of 1,389 consecutive patients with STEMI were assessed by the emergency medical services (EMS) and
referred for primary PCI: 822 (59.2%) were referred directly from the field to a PCI center, and 567 (40.8%)
were transported to a non–PCI-capable hospital first. Death at 180 days occurred in 5.0% of patients transferred
directly from the field, and in 11.5% of patients transported from the field to a non–PCI-capable hospital (p 
0.0001. After adjusting for baseline characteristics in a multivariable logistic regression model, mortality remained
lower among patients referred directly from the field to the PCI center (odds ratio: 0.52, 95% confidence interval:
0.31 to 0.88, p  0.01). Similar results were obtained by using propensity score methods for adjustment.
Conclusions A STEMI system allowing EMS to transport patients directly to a primary PCI center was associated with a signifi-
cant reduction in mortality. Our results support the concept of STEMI systems that include pre-hospital referral
by EMS. (J Am Coll Cardiol 2012;60:1223–30) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.008Primary percutaneous coronary intervention (PCI) has be-
come the dominant reperfusion strategy for ST-segment
elevation myocardial infarction (STEMI) as it is superior to
fibrinolytic therapy in reducing death, reinfarction, and
stroke (1). Nonetheless, to be effective, primary PCI needs to
be performed promptly as delays in door-to-balloon times
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accepted July 3, 2012.strongly correlate with mortality (2,3). Current guidelines
recommend that first medical contact-to-balloon time be
within 90 min for patients presenting to a PCI-capable
hospital and within 120 min for patients presenting to a
non–PCI-capable hospital (4). Unfortunately, many hospitals
do not have a catheterization laboratory, and the transfer
process to a PCI-capable hospital may be associated with long
delays to reperfusion (5). Therefore, it has been proposed that
regions develop STEMI systems that incorporate standardized
protocols to facilitate rapid transfer of STEMI patients (6).
We have previously shown that recommended guideline
door-to-balloon times are achieved more often when pa-
tients are identified in the field by trained paramedics and
transported directly to a designated center for primary PCI
as compared to when patients are evaluated by physicians in
the city emergency department (ED) of non–PCI-capable
hospitals (7). A recent Danish study concluded that the time
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Transfer From the Field for Primary PCI October 2, 2012:1223–30from first contact with the health
care system to the initiation of
reperfusion therapy (system de-
lay) may be more relevant than
door-to-balloon time, as the for-
mer proved to be an independent
predictor of subsequent mortality
in patients with STEMI treated
with primary PCI (8). It remains
to be determined whether mortal-
ity has been changed by building
STEMI systems with pathways
for rapid transportation of patients
to specialized cardiac centers for
primary PCI. Hence, we com-
pared the mortality for patients
referred directly from the field to a
PCI-capable center and the mor-
tality for patients who were trans-
ported to a non–PCI-capable hos-
pital first.
Methods
Study protocol. The University of Ottawa Heart Institute
is a tertiary center located in the city of Ottawa that works
in collaboration with regional hospitals for the delivery of
cardiac care. This center is the only PCI-capable hospital
for the region, and because it does not have an ED, all
primary PCI referrals are evaluated in a dedicated
Abbreviations
and Acronyms
ACC  American College of
Cardiology
AHA  American Heart
Association
CI  confidence interval
ECG  electrocardiogram
ED  emergency
department
EMS  emergency medical
services
OR  odds ratio
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarction
Baseline Characteristics of Pre-Hospital PatientTable 1 Baseline Characteristics of Pre-Hos
Characteristic
Field to
PCI-Capable Ho
(n  822
Age, yrs 62.4 13
Age 75 yrs 174 (21.2
Male 591 (71.9
Hypertension 380 (46.8
Diabetes mellitus 113 (13.8
Current smoker 334 (41.0
History of hyperlipidemia 336 (42.4
Previous myocardial infarction 107 (13.2
Previous stroke 54 (6.6)
Previous angioplasty 81 (10.0
Previous bypass surgery 30 (3.7)
Anterior myocardial infarction 313 (38.2
Heart rate, beats/min 76.2 17
Systolic blood pressure, mm Hg 129.6 24
Diastolic blood pressure, mm Hg 77.7 15
Killip class
I 720 (87.8
II 96 (11.7
III 4 (0.5)
Body mass index, kg/m2 27.2 4.
Creatinine clearance, ml/min 71.9 21Values are mean  SD or n (%).
PCI  percutaneous coronary intervention.STEMI room in proximity to the catheterization labo-
ratories. In May 2005, primary PCI became the standard
of care for the city of Ottawa, which has a population of
900,000.
We used data from the Institute’s prospective STEMI
registry to evaluate the outcomes of consecutive patients
with confirmed STEMI referred for primary PCI between
May 1, 2005, and April 30, 2011, who used the emergency
medical services (EMS) as the initial mode of transportation
within the city boundaries. Patients were divided into 2
groups on the basis of the transport pathway used by the
EMS providers.
The first group (field to PCI-capable hospital) consisted
of patients referred directly to the PCI center by the EMS
providers who bypassed the 4 city hospital EDs, all located
within 7 miles of the PCI center. In these circumstances,
the EMS providers were trained at interpreting the 12-lead
electrocardiogram (ECG) and at independently triaging
patients with STEMI (9). None of the city ambulances were
equipped with ECG transmission capability, and the fur-
thest point of service was 37 miles from the PCI center. All
patients with onset of symptoms of12 h and at least 1 mm
ST-segment elevation in 2 or more contiguous limb leads or
at least 2 mm in 2 or more contiguous precordial leads on
the pre-hospital 12-lead ECG were eligible for direct
transfer to the PCI center. The EMS alerted a central page
operator using a dedicated STEMI line located at the PCI
center of the impending arrival of a patient, which activated
the STEMI code.
erred for Primary PCIPatients Referred for Primary PCI
Field to
Non–PCI-Capable Hospital
(n  567) p Value
63.7 13.4 0.08
134 (23.6) 0.28
380 (67.0) 0.06
294 (53.0) 0.03
143 (25.4) 0.0001
224 (40.1) 0.78
237 (42.9) 0.87
103 (18.5) 0.009
59 (10.6) 0.01
74 (13.3) 0.07
26 (4.6) 0.40
239 (42.2) 0.14
77.3 21.8 0.31
133.8 27.4 0.004
78.7 17.2 0.27
0.0001
493 (87.0)
55 (9.7)
19 (3.4)
28.0 5.8 0.005
70.6 24.6 0.29s Refpital
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October 2, 2012:1223–30 Transfer From the Field for Primary PCIThe second group (field to non–PCI-capable hospital)
included patients transported from the field to the nearest
ED and subsequently referred to the PCI center. Patients
belonging to this group were initially transported to a
non–PCI-capable hospital because paramedics trained at
interpreting the ECG were not present at the scene, or the
pre-hospital ECG was either not performed or did not
qualify for STEMI. At the non–PCI-capable hospital, all
patients with onset of symptoms of12 h and at least 1 mm
ST-segment elevation in 2 or more contiguous leads on the
12-lead ECG were eligible for immediate transfer to the
PCI center for primary PCI. The emergency medicine
physician was empowered to activate the STEMI code.
We excluded patients who presented with cardiogenic
shock and patients who remained comatose after resuscita-
tion, as these patients were usually transported to the nearest
ED before referral for primary PCI. We also excluded
patients who self-transported to the ED.
All patients received chewable aspirin 160 mg, oral clopi-
dogrel 600 mg, and unfractionated heparin 60 U/kg (maxi-
mum 4,000 U) intravenously before the PCI procedure.
Procedural ResultsTable 2 Procedural Results
Variable
F
PCI-Cap
(n
Catheterization performed 81
Femoral access 71
PCI performed 76
Stenting performed 75
No. of stents per patient 1
Glycoprotein IIb/IIIa inhibitor 24
Bivalirudin 32
First hospital arrival to balloon inflation, min 6
Symptom onset to balloon inflation, min 159
Angiographic results
Multivessel disease 44
Infarct-related artery
Left main coronary*
Left anterior descending 32
Left circumflex 9
Right coronary 38
Bypass graft
Unknown
Coronary flow at baseline
TIMI grade 0 49
TIMI grade 1 5
TIMI grade 2 9
TIMI grade 3 17
Coronary flow after procedure
TIMI grade 0 2
TIMI grade 1
TIMI grade 2 3
TIMI grade 3 74
Diameter stenosis before procedure 97
Diameter stenosis after procedure 1Values are n (%), mean  SD, or median (interquartile range). *One patient in
IQR  interquartile range; PCI  percutaneous coronary angioplasty; TIMIStudy endpoints and definitions. The primary outcome
was all-cause mortality measured at 180 days. Secondary
outcomes included in-hospital reinfarction, stroke, and
cardiogenic shock that developed after hospital admission,
as previously defined (7). Stent thrombosis was recorded as
definite or probable, as defined by the Academic Research
Consortium (10). Episodes of bleeding were defined as
major or minor according to the TIMI (Thrombolysis In
Myocardial Infarction) classification (11). The door-to-
balloon time was defined as the time elapsed between arrival
at the first hospital and the time of first device use or balloon
inflation. In cases referred directly from the field, the first
hospital was the cardiac center. The study was approved by
the institutional ethics review board.
Statistical analysis. Proportions and means with standard
deviations were used to describe categorical and continuous
variables respectively. Categorical variables were compared
using chi-square tests. The Student t test was used to
compare normally distributed continuous variables, and the
Mann-Whitney U test was used for variables that were not
normally distributed.
ospital
2)
Field to
Non–PCI-Capable Hospital
(n  567) p Value
) 560 (98.8) 0.14
) 482 (86.1) 0.37
) 512 (90.3) 0.06
) 498 (88.9) 0.05
.9 1.4 0.9 0.84
) 194 (34.2) 0.10
) 168 (29.6) 0.0002
82) 117 (93–145) 0.0001
221) 231 (170–365) 0.0001
) 334 (58.9) 0.08
0.03
6 (1.1)
) 230 (41.1)
) 72 (12.9)
) 233 (41.6)
13 (2.3)
6 (1.1)
0.003
) 283 (50.7)
43 (7.7)
) 83 (14.9)
) 149 (26.7)
0.48
23 (4.1)
10 (1.8)
23 (4.1)
) 500 (89.9)
.2 96.7 8.3 0.02
1.0 2.6 15.1 0.12ield to
able H
 82
7 (99.5
7 (87.8
4 (93.1
2 (92.0
.4 0
6 (29.9
2 (39.2
6 (42–
(120–
5 (54.1
1 (0.1)
0 (39.2
9 (12.1
2 (46.8
8 (0.9)
7 (0.8)
5 (60.8
4 (6.6)
3 (11.4
2 (21.1
5 (3.1)
9 (1.1)
1 (3.8)
9 (92.0
.6 6
.4 1each group had complete occlusion of the left main coronary artery.
 Thrombolysis In Myocardial Infarction.
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Transfer From the Field for Primary PCI October 2, 2012:1223–30The impact of the transport pathway on mortality at
180 days was assessed for both univariable and multivari-
able associations using logistic regression models. For the
multivariable analysis, the independent effect of the
transport pathway on mortality was assessed by control-
ling for baseline characteristics related to mortality in the
univariable analysis (p  0.15). We excluded time-to-
balloon intervals because of the previously demonstrated
relationship between direct field transfer and interhospi-
tal transfer (7). We constructed a second model that
included the baseline characteristics as well as imbalances
between groups (p  0.15) in the treatment received
uring the initial cardiac catheterization. In addition,
ropensity scores were derived using the baseline charac-
eristics as predictors in a logistic regression model using
he transport pathway as the outcome; a logistic regres-
ion model adjusted for the propensity score variable was
hen fitted. Finally, propensity score matching was per-
ormed using the propensity scores. Patients in the 2
roups were matched if their propensity score was within
0.05. A matched analysis using conditional logistic
egression was used to determine the effect of the
ransport pathway. Verification of the balance of baseline
ovariates in the matched data was done using a paired
test for continuous variables and conditional logistic
egression for categorical variables. Analyses were con-
ucted using SAS version 9.2 (SAS Institute, Cary,
orth Carolina). A p value of 0.05 was considered
tatistically significant.
In-Hospital Clinical Outcomes and Mortality at FTable 3 In-Hospital Clinical Outcomes and M
Outcomes
Field to
PCI-Capable Hos
(n  822)
Death 25 (3.0)
Reinfarction 11 (1.3)
Stroke 6 (0.7)
Death, reinfarction, or stroke 41 (5.0)
Cardiogenic shock 31 (3.8)
Stent thrombosis 9 (1.1)
Bleeding
Non-CABG major 25 (3.1)
Non-CABG minor 53 (6.7)
Non-CABG major or minor 78 (9.8)
Any major 32 (3.9)
Blood transfusion 37 (4.5)
Revascularization procedures
Repeat PCI 16 (2.0)
Noninfarct-related artery PCI 98 (11.9)
Bypass surgery 26 (3.2)
Length of stay, days 4 (3–6)
Death at follow-up
At 30 days 29/800 (3.2
At 180 days 39/779 (5.0Values are n (%), median (interquartile range), or n/N (%). *Does not include
CABG  coronary artery bypass surgery; other abbreviations as in Table 2.esults
atient characteristics. During the study period, we eval-
ated 1,389 consecutive STEMI patients who called 911
nd were referred for primary PCI. Among these patients,
22 (59.2%) were referred directly from the field to the PCI
enter, and 567 (40.8%) were referred from the field to a
on–PCI-capable hospital. The baseline characteristics of
he patients are shown in Table 1. Patients in the group who
ere transported to a non–PCI-capable hospital were more
ikely to have a history of hypertension (53.0% vs. 46.8%,
 0.03), diabetes mellitus (25.4% vs. 13.8%, p  0.0001),
revious myocardial infarction (18.5% vs. 13.2%, p 
.009), and previous stroke (10.6% vs. 6.6%, p  0.01);
hese patients were also more likely to present with a higher
illip class (p 0.0001) and higher body mass index (28.0 5.8
g/m2 vs. 27.2  4.8 kg/m2, p  0.005).
Treatment and procedures. Selective coronary angiogra-
phy was performed in 99.1% of all patients. The angio-
graphic and procedural results are shown in Table 2.
Primary PCI was performed in 93.1% of patients referred
directly from the field, and in 90.3% of patients referred
from the field to a non–PCI-capable hospital (p 0.06). At
he time of cardiac catheterization, patients referred directly
rom the field were more likely to receive bivalirudin as an
nticoagulant (39.2% vs. 29.6%, p  0.0002). However,
here was no difference between the 2 groups in the use of
latelet glycoprotein IIb/IIIa inhibitors.
The median door-to-balloon time was shorter for pa-
ients referred directly from the field (66 min; interquartile
-Uplity at Follow-Up
Field to
Non–PCI-Capable Hospital
(n  567) p Value
46 (8.1) 0.0001
7 (1.2) 1.00
7 (1.2) 0.40
55 (9.7) 0.0007
43 (7.6) 0.002
7 (1.2) 0.80
30 (5.6) 0.04
66 (12.2) 0.0005
96 (17.7) 0.0001
35 (6.2) 0.06
42 (7.4) 0.03
9 (1.6) 0.62
58 (10.2) 0.34
26 (4.6) 0.19
4 (3–7) 0.36
43/558 (7.7)* 0.001
63/550 (11.5) 0.0001olloworta
pital
)
)3 patients who died during initial hospitalization beyond 30 days.
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October 2, 2012:1223–30 Transfer From the Field for Primary PCIrange: 42 to 82 min) as compared to patients transported
from the field to the non–PCI-capable hospital (117 min;
interquartile range: 93 to 145 min; p  0.0001). Door-to-
balloon times of 90 min were achieved in 82.6% of
patients transferred directly from the field and in only 20.8%
of patients in the non–PCI-capable hospital group (p 
0.001).
The proportion of patients with the culprit for the
infarction being the left main coronary artery was higher
among patients transported from the field to the non–PCI-
capable hospital (1.1%) as compared to patients transported
from the field directly to the PCI center (0.1%; p  0.02);
however, only 1 patient in each group had complete occlu-
sion of the left main coronary artery. The proportion of
patients with TIMI flow grade 3 at baseline was lower
among patients transported directly to the PCI center
(21.1% vs. 26.7%, p  0.02). However, the proportion of
atients achieving TIMI flow grade 3 after the procedure
as not different between the 2 groups: 92.0% versus 89.9%,
espectively (p  0.13).
During the initial hospitalization, bypass surgery was
erformed in 3.2% of patients transported directly from the
eld and in 4.6% of patients transported from the field to a
on–PCI-capable hospital (p  0.19).
Figure 1 Results of Univariable Logistic Regression Analysis
The results of the univariable analysis revealed that several baseline characteristi
myocardial infarction patients referred for primary percutaneous coronary interventAt discharge, aspirin was prescribed for 99.3% of patients
ransferred from the field to the PCI center and for 97.5%
f patients transported to a non–PCI-capable hospital (p 
.02); clopidogrel for 96.4% versus 93.7% (p  0.03);
eta-blockers for 94.7% versus 93.0% (p  0.27);
ngiotensin-converting enzyme inhibitors for 82.8% versus
1.8% (p  0.66); angiotensin-receptor blockers for 4.3%
ersus 6.3% (p  0.10); and statins for 97.4% versus 96.0%
p  0.20), respectively.
linical outcomes. Clinical outcomes are shown in Table 3.
ollow-up was available for 1,329 patients (96%) at 180
ays. The primary outcome consisting of all-cause death at
80 days occurred in 5.0% of patients in the field to PCI
apable hospital group and in 11.5% of patients in the group
ransported to a non–PCI-capable hospital first (p 
.0001).
The results of the univariable analysis showed that several
aseline characteristics were associated with mortality at 180
ays (Fig.1). Using multivariable analysis to adjust for
aseline characteristics, mortality remained significantly
ower among patients referred directly to the PCI center, in
omparison to patients referred from the field to the ED
odds ratio [OR]: 0.52, 95% confidence interval [CI]: 0.31
o 0.88, p  0.01) (Fig. 2). The C-statistic was 0.88. Other
e associated with mortality at 180 days in ST-segment elevation
I). The odds ratios and corresponding 95% confidence intervals (CIs) are shown.cs wer
ion (PC
f
l
w
a
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Transfer From the Field for Primary PCI October 2, 2012:1223–30baseline characteristics that were independently associated
with mortality at 180 days were diabetes mellitus, higher
Killip class, left main as the culprit artery, increasing age,
higher heart rate, and lower creatinine clearance. To correct
for imbalances in the treatment received during cardiac
catheterization, we included the following variables in the
second multivariable model: actual performance of PCI, the
use of bivalirudin, and the use of glycoprotein IIb/IIIa
inhibitors. Mortality remained significantly lower among
patients referred directly from the field to the PCI center
(OR: 0.44, 95% CI: 0.25 to 0.77, p  0.003).
In a separate analysis adjusting for the propensity score
variable, mortality was lower among the group of patients
referred directly from the field to the PCI center (OR: 0.50,
95% CI: 0.31 to 0.79, p  0.003, C  0.67). After
matching on propensity scores and conducting a paired
analysis, the OR for mortality was 0.37 (95% CI: 0.21 to
0.65, p 0.0005), again favoring the group referred directly
rom the field to the PCI center. The C-statistic for the
ogistic regression model used to derive the propensity score
as 0.63. The verification of the balance in baseline char-
cteristics in the propensity score matched data is shown in
able 4.
iscussion
e have developed a STEMI system that provides systematic
Figure 2 Results of Multivariable Logistic Regression Analysis
The results of the multivariable logistic regression analysis of baseline characteris
tion patients referred for primary percutaneous coronary intervention (PCI) are sho
cantly lower mortality in comparison to the group of patients transported from the
0.31 to 0.88, p  0.01). *Odds ratios and CI were reported for a 10-U incrementpplication of primary PCI for an entire city using standardizedprotocols designed to reduce time to reperfusion. As a result of
this system design, mortality was significantly lower among
patients identified in the field by EMS and transported directly
to a designated PCI center as compared to patients first
transported to a non–PCI capable hospital.
STEMI systems improve regional access to primary PCI
and reduce delays to reperfusion (7,12,13). The 2009
American College of Cardiology/American Heart Associa-
tion (ACC/AHA) STEMI guidelines recommend that we
develop such systems of care to increase the number of
patients with timely access to primary PCI (14). In this
report, STEMI patients transported directly to a PCI center
had a significant reduction in mortality. Our results under-
score the importance of pre-hospital diagnosis of STEMI
and direct transfer to a PCI center, bypassing the ED of
non–PCI-capable hospitals whenever possible. The design
of such STEMI systems results in shorter time to reperfu-
sion, which is unquestionably the primary mechanism for
lowering mortality. Among 43,801 patients in the National
Cardiovascular Data Registry, any delay in primary PCI
after hospital arrival was associated with a higher adjusted
risk of mortality in a continuous, nonlinear fashion (15).
These data support the position taken by the ACC/AHA
guidelines that every minute counts and that the time to
treatment should be “as soon as possible,” rather than simply
accepting the standard door-to-balloon of 90 min as
sociated with mortality at 180 days in ST-segment elevation myocardial infarc-
e group of patients referred directly from the field to the PCI center had signifi-
o a non–PCI-capable hospital (odds ratio: 0.52, 95% confidence interval [CI]:
ge.tics as
wn. Th
field t
al chansatisfactory (14).
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October 2, 2012:1223–30 Transfer From the Field for Primary PCIWide adoption of the pre-hospital ECG has not yet
occurred in North America (16). Obtaining a pre-hospital
ECG is a critical component of the STEMI system. Early
recognition of STEMI allows for direct transport of patients
to the nearest PCI center and early activation of the
catheterization laboratory (9). Hospitals that use the results
of the pre-hospital ECG have significantly faster door-to-
balloon times than hospitals that do not use the pre-hospital
ECG (6). A recent pooled analysis of 10 independent
registries involving 72 hospitals in the United States re-
ported that pre-hospital triage with ECGs was associated
with an 86% rate of door-to-balloon time of 90 min (17).
These results are similar to ours and show a notable
improvement over the previously published national average
rate of 50% (18).
Reducing the time spent in the ED should be a priority
or all patients transferred for primary PCI. Our results
mphasize that the process of triaging patients in the ED is
ssociated with inevitable delays to reperfusion. The median
elay from ED arrival to departure was 54 min. Fibrinolysis
ould have been used as an alternative reperfusion strategy;
owever, primary PCI was likely the better choice, as
eperfusion was achieved in the majority of the patients and
he median door-to-balloon time was 120 min as recom-
mended by the updated ACC/AHA guidelines (4).
Patients transported by EMS are known to have a much
higher risk profile in comparison to patients who self-
transport (19). The benefit associated with triage in the field
Baseline Characteristics for the Propensity ScoTable 4 Baseline Characteristics for the Pro
Characteristic
Field to
PCI-Capable Ho
(n  518
Age, yrs 63.1 13
Male 352 (67.6
Hypertension 262 (50.3
Diabetes mellitus 104 (20.0
Current smoker 213 (40.9
History of hyperlipidemia 221 (42.4
Previous myocardial infarction 78 (15.0
Previous stroke 45 (8.6)
Previous angioplasty 62 (11.9
Previous bypass surgery 22 (4.2)
Anterior myocardial infarction 213 (40.9
Heart rate, beats/min 75.6 16
Systolic blood pressure, mm Hg 134.3 24
Killip class
I 448 (86.0
II 69 (13.2
III 4 (0.8)
Body mass index, kg/m2 27.9 5.0
Creatinine clearance, ml/min 72.1 21
Multivessel disease 297 (57.0
Left main culprit artery 1 (0.2)
Values are mean  SD or n (%).
PCI  percutaneous coronary intervention.was somewhat anticipated as the mortality rate reductionwith shorter door-to-balloon time is greater in high-risk
patients presenting early (20,21). It remains that efforts be
made to shorten door-to-balloon times for all patients
because this variable strongly correlates with mortality,
regardless of the baseline risk of mortality (3). Hence, all
paramedics in the city of Ottawa now receive ECG training
to ensure that the maximal number of STEMI patients be
transported directly from the field to the PCI center.
Study limitations. First, it was not a randomized trial, and
it is possible that unappreciated or immeasurable confound-
ing variables could have altered the results. However, it is
now virtually impossible to randomize patients with
STEMI identified in the pre-hospital setting to compare
transfer directly to a PCI center with transfer to a non–
PCI-capable hospital. To reduce confounding variables, we
excluded patients with cardiogenic shock and patients who
remained comatose after resuscitation, as these patients
were more likely transported to the local ED before referral
for primary PCI. Delays caused by cardiac arrest and/or
cardiogenic shock are associated with high in-hospital
mortality (22), and the inclusion of these patients in the
analysis would likely have biased the results. That is not to
say that whenever possible patients with shock should not
be transferred directly to a PCI center, as the survival benefit
of rapid reperfusion may be the greatest for these patients
(23). Second, our results may not apply to regions where
trained paramedics are not available to establish STEMI in
the pre-hospital setting. We believe that our results are
tched Dataity Score Matched Data
Field to
Non–PCI-Capable Hospital
(n  518) p Value
63.3 13.3 0.79
347 (67.0) 0.82
273 (52.7) 0.40
121 (23.4) 0.07
207 (40.0) 0.78
213 (41.1) 0.67
88 (17.0) 0.31
51 (9.9) 0.47
69 (13.3) 0.40
21 (4.1) 0.96
217 (41.9) 0.75
76.8 21.9 0.33
133.5 26.4 0.61
0.007
451 (87.1)
49 (9.5)
18 (3.5)
28.0 5.8 0.59
70.3 24.1 0.16
301 (58.1) 0.69
3 (0.6) 0.98re Mapens
spital
)
.7
)
)
)
)
)
)
)
)
.2
.8
)
)
.1
)applicable to most regions. In the United States, the
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Transfer From the Field for Primary PCI October 2, 2012:1223–30median time to the closest PCI hospital is 11.4 min and
the median distance is 8.0 miles, with nearly 80% of the
adult population living within 60 min of activation of the
EMS to arrival at a PCI center (24). In Ontario, it is
estimated that 55% to 65% of patients presenting with
STEMI live within 30 min of a PCI center (25).
Conclusions
The design of a STEMI system permitting EMS to bypass
the nearest ED and transport patients directly to a receiving
center for primary PCI was associated with a significant
reduction in mortality. Our results underscore the impor-
tance of developing STEMI systems that allow triage in the
pre-hospital setting by trained EMS and facilitate rapid
transport of patients directly to a PCI center.
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